05/29/2024
4:01 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
7:05 AM | Budur Kumar (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
8:44 AM | Harmony Biosciences (Filer)
| Form ARS | |
04/11/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/11/2024
7:17 AM | Harmony Biosciences (Filer)
| Form DEF 14A | |
04/11/2024
7:18 AM | Harmony Biosciences (Filer)
| Form DEFA14A | |
03/18/2024
6:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:17 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:21 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:16 PM | Harmony Biosciences (Filer)
| Form 10-K/A | |
02/22/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:06 PM | Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
| Form SC 13G/A | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
| Form SC 13G/A | |
01/08/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
7:59 AM | Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/08/2023
8:03 AM | Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
7:15 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
7:31 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
10/11/2023
7:15 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
1:34 PM | BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
| Form SC 13G/A | |
10/05/2023
3:15 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
3:15 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
7:12 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
09/25/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:59 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
09/14/2023
3:42 PM | Harmony Biosciences (Filer)
| Form 8-K/A | |
08/28/2023
7:23 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T | |
08/24/2023
4:23 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC 13D | |
08/14/2023
4:26 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-C | |
08/14/2023
4:27 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:29 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-C | |
08/01/2023
7:01 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Dems have chosen Biden replacement? (Ad) On November 16, 2023…
Joe Biden accidentally revealed the name of the candidate…
Who will replace him in the 2024 presidential election. See who it is HERE. |
08/01/2023
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/27/2023
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
3:37 PM | Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Issuer)
| Form 4/A | |
